Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2009 3
2010 11
2011 8
2012 3
2013 6
2014 1
2015 4
2016 8
2017 5
2018 10
2019 4
2020 1
2021 3
2022 2
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Deferiprone in Parkinson's Disease.
Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon Delannoy P, Poewe W, Compta Y, Pavese N, Růžička E, Dušek P, Post B, Bloem BR, Berg D, Maetzler W, Otto M, Habert MO, Lehericy S, Ferreira J, Dodel R, Tranchant C, Eusebio A, Thobois S, Marques AR, Meissner WG, Ory-Magne F, Walter U, de Bie RMA, Gago M, Vilas D, Kulisevsky J, Januario C, Coelho MVS, Behnke S, Worth P, Seppi K, Ouk T, Potey C, Leclercq C, Viard R, Kuchcinski G, Lopes R, Pruvo JP, Pigny P, Garçon G, Simonin O, Carpentier J, Rolland AS, Nyholm D, Scherfler C, Mangin JF, Chupin M, Bordet R, Dexter DT, Fradette C, Spino M, Tricta F, Ayton S, Bush AI, Devedjian JC, Duce JA, Cabantchik I, Defebvre L, Deplanque D, Moreau C; FAIRPARK-II Study Group. Devos D, et al. N Engl J Med. 2022 Dec 1;387(22):2045-2055. doi: 10.1056/NEJMoa2209254. N Engl J Med. 2022. PMID: 36449420 Clinical Trial.
Progression to Parkinson's dementia is not modulated by genetic risk variants for Alzheimer's or Parkinson's disease.
Parveen K, Ross JA, van der Wurp H, Balzer-Geldsetzer M, Berg D, Deuschl G, Gasser T, Hilker-Roggendorf R, Kalbe E, Liepelt-Scarfone I, Mollenhauer B, Riedel O, Röske S, Schulz JB, Spottke A, Storch A, Trenkwalder C, Kassubek J, Witt K, Dodel R, Wüllner U, Ramirez A, Dalmasso MC. Parveen K, et al. Among authors: balzer geldsetzer m. J Parkinsons Dis. 2025 Jul 30:1877718X251356512. doi: 10.1177/1877718X251356512. Online ahead of print. J Parkinsons Dis. 2025. PMID: 40739885 Free article.
Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson's Disease.
Michels J, van der Wurp H, Kalbe E, Rehberg S, Storch A, Linse K, Schneider C, Gräber S, Berg D, Dams J, Balzer-Geldsetzer M, Hilker-Roggendorf R, Oberschmidt C, Baudrexel S, Witt K, Schmidt N, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Spottke A, Roeske S, Wüllner U, Wittchen HU, Riedel O, Kassubek J, Dodel R, Schulz JB, Costa AS, Reetz K. Michels J, et al. Among authors: balzer geldsetzer m. J Parkinsons Dis. 2022;12(3):905-916. doi: 10.3233/JPD-212787. J Parkinsons Dis. 2022. PMID: 35068416 Free article.
TREM2 rare variant p.R47H is not associated with Parkinson's disease.
Mengel D, Thelen M, Balzer-Geldsetzer M, Söling C, Bach JP, Schaeffer E, Herold C, Becker T, Liepelt I, Becker J, Riedel-Heller S, Scherer M, Jessen F, Maier W, Dodel R, Ramirez A. Mengel D, et al. Among authors: balzer geldsetzer m. Parkinsonism Relat Disord. 2016 Feb;23:109-11. doi: 10.1016/j.parkreldis.2015.11.026. Epub 2015 Nov 25. Parkinsonism Relat Disord. 2016. PMID: 26651418
Use of antidementia drugs in German patients with Alzheimer's disease.
Hessmann P, Dodel R, Baum E, Müller MJ, Paschke G, Kis B, Zeidler J, Klora M, Reese JP, Balzer-Geldsetzer M. Hessmann P, et al. Among authors: balzer geldsetzer m. Int Clin Psychopharmacol. 2018 Mar;33(2):103-110. doi: 10.1097/YIC.0000000000000205. Int Clin Psychopharmacol. 2018. PMID: 29112517
Who was the man who discovered the "Lewy bodies"?
Rodrigues e Silva AM, Geldsetzer F, Holdorff B, Kielhorn FW, Balzer-Geldsetzer M, Oertel WH, Hurtig H, Dodel R. Rodrigues e Silva AM, et al. Among authors: balzer geldsetzer m. Mov Disord. 2010 Sep 15;25(12):1765-73. doi: 10.1002/mds.22956. Mov Disord. 2010. PMID: 20669275
Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.
Wojtala J, Heber IA, Neuser P, Heller J, Kalbe E, Rehberg SP, Storch A, Linse K, Schneider C, Gräber S, Berg D, Dams J, Balzer-Geldsetzer M, Hilker-Roggendorf R, Oberschmidt C, Baudrexel S, Witt K, Schmidt N, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Spottke A, Roeske S, Wüllner U, Wittchen HU, Riedel O, Dodel R, Schulz JB, Reetz K. Wojtala J, et al. Among authors: balzer geldsetzer m. J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):171-179. doi: 10.1136/jnnp-2018-319008. Epub 2018 Oct 8. J Neurol Neurosurg Psychiatry. 2019. PMID: 30297519
Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.
Mengel D, Dams J, Ziemek J, Becker J, Balzer-Geldsetzer M, Hilker R, Baudrexel S, Kalbe E, Schmidt N, Witt K, Liepelt-Scarfone I, Gräber S, Petrelli A, Neuser P, Schulte C, Linse K, Storch A, Wittchen HU, Riedel O, Mollenhauer B, Ebentheuer J, Trenkwalder C, Klockgether T, Spottke A, Wüllner U, Schulz JB, Reetz K, Heber IA, Ramirez A, Dodel R. Mengel D, et al. Among authors: balzer geldsetzer m. Parkinsonism Relat Disord. 2016 Aug;29:112-6. doi: 10.1016/j.parkreldis.2016.04.013. Epub 2016 Apr 19. Parkinsonism Relat Disord. 2016. PMID: 27321987
64 results